A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity by Regina Michelis (2889092)

“…In patients with abnormal C5, basal levels of sC5b-9 and C5a were increased while activities of the CP and of the CP C5-convertase, the immediate C5-upstream complex, were decreased compared to NC and to patients with normal C5. …”

Flies decrease the level of aggression as the availability of food resource increases. by Rod S. Lim (622045)

Examining physiotherapist use of structured aerobic exercise testing to decrease barriers to aerobic exercise by Evan Foster, B.Sc. (5051426)

Celecoxib decreases the viability of MDA-MB-231-and MDA-MB-435-stable transfectants by Takeshi Sugimoto (84349)

Knockdown of <i>SfDredd</i> led to decreased apoptosis induced by ActD. by Zhouning Yang (201755)

Mutation of the genes encoding the SpuDEFGH transporter decreased the expression of T3SS genes. by Lian Zhou (272766)

Decreased chymotrypsin-like activity of proteasomes in U87MG cells that express PTEN. by Rajaa Errafiy (497050)

Changes in baseline CD4 count through week 12 and week 24 according to the linear regression model. by Tosi M. Mwakyandile (16408705)

DTG mice have significantly decreased troponin I phosphorylation and Serca2 expression. by Sarah N. Cilvik (495882)

“…<p>(A) Representative Western blots depicting no changes in the expression of phosphorylated protein kinase A (P-PKA) and decreased expression of phosphorylated troponin I (P-TnI) and Serca2. ß-tubulin was used as a loading control. …”

Taurocholate significantly decreases toxin B-mediated Caco-2 cell membrane integrity. by Charles Darkoh (482779)

Bay 61–3606 sensitizes MCF-7 cells to TRAIL by decreasing Mcl-1. by So-Young Kim (562174)

Nepmucin/CD300LG expression is decreased in tumors and tumor-draining lymph nodes. by Eiji Umemoto (1637)

Decreased Aβ oligomer immunoreactivity in APPxPS1 mice after treatment with hNGFP61S/R100E: polyclonal pAb A11 antibody. by Simona Capsoni (161132)

Fluoxetine decreases the levels of abundant neuropeptides (NPY and CART) in hypothalamic differentiated neuroprogenitor cells. by Lígia Sousa-Ferreira (221509)

“…<p>Fluoxetine decreases the mRNA levels of neuropeptides that are abundant in differentiated hypothalamic neuroprogenitor cultures NPY (<b>A</b>) and CART (<b>D</b>), but has no effect in the mRNA of AgRP (<b>B</b>) and POMC (<b>C</b>). …”

Inhibition of the <i>Hedgehog</i> pathway leads to decreased ostegenesis <i>in vitro</i>. by Emily R. Nelson (247130)

“…<p>(A–B) qRT-PCR of e13.5 wild-type, CD-1 palate cultures treated with DMEM F12 +/− supplementation with cyclopamine (20 mM) or Shh-N (250 ng/mL) for 2 days. …”

<b>Glucagon Clearance is Decreased in Chronic Kidney Disease, but Preserved in Liver Cirrhosis</b> by Magnus F. G. Grøndahl (19160825)

Substrate reduction therapy normalizes urine volume and decreases urine GL-3 levels. by John Marshall (39501)

Quantitation demonstrates the overlap of WFA ‘patches’ and striosomes decreases during early postnatal development. by Hyunchul Lee (52763)

“…(B) Overlap between WFA clusters and S and M compartments at P10. Although ‘patches’ remain overwhelmingly associated with striosomes (Student's <i>t</i>-test; P = 2.1063×10⁻⁵), the absolute area of overlap with both neostriatal subcompartments has dropped significantly by this time compared with P4 (note difference in scale for A and B; Two-way ANOVA, age and subregion as factors; F(1, 32) = 96.65, P = 3.4327×10⁻¹¹ across ages; F(1, 32) = 119.2, P = 2.5329×10⁻¹² across subregions; F(1, 32) = 52.2, P = 3.3113×10⁻⁸ for interactions between age and subregion). …”

Het GIP Tg mice exhibited decreased physical activity but unaltered energy expenditure. by Su-Jin Kim (90561)

GB pretreatment decreased the level of reactive oxygen species (ROS) in cardiomyocytes treated with DOX. by Junqing Gao (3545495)